Koers Easton Pharmaceuticals Inc. Other OTC
Aandelen
EAPH
US2777741057
Biotechnologie & Medisch Onderzoek
Omzet 2019 | 1,56 mln. 1,44 mln. | Omzet 2020 | - | Marktkapitalisatie | 807K 747K |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | - 0 | Nettowinst (verlies) 2020 | - 0 | EV/omzet 2019 | 6,27 x |
Nettoschuld 2019 | 8,41 mln. 7,79 mln. | Nettoschuld 2020 | 2,48 mln. 2,3 mln. | EV/omzet 2020 | - |
K/w-verhouding 2019 |
-4,17
x | K/w-verhouding 2020 |
-4,29
x | Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30-06-15 |
Vince Demasi
COO | Chief Operating Officer | - | 20-06-18 |
Chief Tech/Sci/R&D Officer | - | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30-06-15 |
John Guerra
SEC | Corporate Secretary | - | 31-12-13 |
Vince Demasi
COO | Chief Operating Officer | - | 20-06-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,72% | 125 mld. | |
+14,19% | 108 mld. | |
-4,93% | 24,21 mld. | |
+3,23% | 22,78 mld. | |
-10,44% | 17,96 mld. | |
-41,74% | 16,43 mld. | |
-13,31% | 16,37 mld. | |
+2,44% | 13,58 mld. | |
+27,89% | 11,66 mld. |